Structure and function of Cannabinoid Receptor Heterodimers
Structure and function of Cannabinoid Receptor Heterodimers
批准号:
RGPIN-2019-04282
负责人:
DenovanWright, Eileen
金额:
$3.06万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
G protein-coupled receptors (GPCR) function via conformational change in response to ligand binding resulting in dynamic protein-protein interactions. Multiple type A GPCR physically associate in heteromeric complexes and the signalling response to ligand binding is dependent on the GPCRs in the complex. Given the differential coupling of GPCRs in different cell types, the response to endogenous ligands and neurotransmitters in different brain regions is more complex than imagined previously. There is a growing interest in understanding the unique properties of heteromers containing cannabinoid receptors in complex with other GPCRs including other cannabinoid receptors, dopamine receptors, adenosine receptors and opioid receptors. The signalling of heteromeric complexes in response to endogenous ligands such as endocannabinoids depends on the relative concentration of receptors, proportion of receptors involved in heteromeric complexes and the local concentration of endogenous ligands. The work proposed is part of a long-term research program to understand how heteromeric GPCRs control basic homeostatic processes including modulation of neurotransmission, neurogenesis, cerebral vascular function and immune responses in the periphery and in the brain. The results of this research program will provide novel information on the function of the ECS, which is now recognized as a major neuro- and immunomodulator for the mammalian brain. Specifically, we will contribute the understanding of the complex regulation of the neurovascular boundary between the brain and periphery during normal development, aging, and during periods of inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure and function of Cannabinoid Receptor Heterodimers
-
批准号:RGPIN-2019-04282
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.06万
-
财政年份:2022
-
负责人:DenovanWright, Eileen
-
依托单位:
Structure and function of Cannabinoid Receptor Heterodimers
-
批准号:RGPIN-2019-04282
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.06万
-
财政年份:2021
-
负责人:DenovanWright, Eileen
-
依托单位:
Structure and function of Cannabinoid Receptor Heterodimers
-
批准号:RGPIN-2019-04282
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.06万
-
财政年份:2019
-
负责人:DenovanWright, Eileen
-
依托单位:
Canadian Council on Animal Care (CCAC) - Grant Renewal 2016-2020
-
批准号:493243-2016
-
项目类别:Unique Initiatives Fund
-
资助金额:$25.5万
-
财政年份:2017
-
负责人:DenovanWright, Eileen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
GASP-1通过Myostatin信号通路调控颏舌肌功能的作用及机制研究
-
批准号:82371131
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:易红良
-
依托单位:
双硫仑结合并抑制谷氨酸脱氢酶1活性调节Th17/Treg细胞平衡的作用与机制探究
-
批准号:82371755
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王秦兰
-
依托单位:
犬尿氨酸酶KYNU参与非酒精性脂肪肝进展为肝纤维化的作用和机制研究
-
批准号:82370874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘才智
-
依托单位: